Kaliandra de Almeida Gonçalves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kaliandra de Almeida Gonçalves has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Jörg Kobarg
Universidade Estadual de Campinas
11 shared publications Luciane França de Oliveira
Laboratório Nacional de Luz Síncrotron (LNLS) , CEP 13083-970, Caixa Postal 6192, Campinas, São Paulo, Brazil
5 shared publications- Mateus Borba Cardoso
Brazilian Synchrotron Light Laboratory (LNLS)
5 shared publications - Gustavo Costa Bressan
Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Viçosa, Av. P. H. Rolfs, s/n, Campus Universitário, CEP: 36570-000 Viçosa, MG, Brasil
4 shared publications - Ângela Saito
Brazilian Center for Research in Energy and Materials (CNPEM), Brazilian Biosciences National Laboratory (LNBio), Campinas, Brazil. Graduate Program in Molecular and Morphofunctional Biology (PPG-BMM), University of Campinas (UNICAMP), Campinas, Brazil
4 shared publications Edmilson Rui
Centro de Biologia Molecular Estrutural, Laboratório Nacional de Luz Síncrotron, Rua Giuseppe Máximo Scolfaro 10.000, C.P. 6192, 13084-971 Campinas, SP, Brazil
3 shared publications
Latest Publications
- Open Access
- 7 November 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 727
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15–20% of breast malignancies are TNBC. Patients with TNBC often have an unfavorable prognosis. In addition, TNBC represents an important clinical challenge since it does not respond to hormone therapy. In this work, we integrated high-throughput mRNA sequencing (RNA-Seq) data from normal and tumor tissues (obtained from The Cancer Genome Atlas, TCGA) and cell lines obtained through in-house sequencing or available from the Gene Expression Omnibus (GEO) to generate a unified list of differentially expressed (DE) genes. Methylome and proteomic data were integrated to our analysis to give further support to our findings. Genes that were overexpressed in TNBC were then curated to retain new potentially druggable targets based on in silico analysis. Knocking-down was used to assess gene importance for TNBC cell proliferation. Our pipeline analysis generated a list of 243 potential new targets for treating TNBC. We finally demonstrated that knock-down of Guanylate-Binding Protein 1 (GBP1 ), one of the candidate genes, selectively affected the growth of TNBC cell lines. Moreover, we showed that GBP1 expression was controlled by epidermal growth factor receptor (EGFR) in breast cancer cell lines. We propose that GBP1 is a new potential druggable therapeutic target for treating TNBC with enhanced EGFR expression.
- 7 November 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 727
Open AccessGuanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15–20% of breast malignancies are TNBC. Patients with TNBC often have an unfavorable prognosis. In addition, TNBC represents an important clinical challenge since it does not respond to hormone therapy. In this work, we integrated high-throughput mRNA sequencing (RNA-Seq) data from normal and tumor tissues (obtained from The Cancer Genome Atlas, TCGA) and cell lines obtained through in-house sequencing or available from the Gene Expression Omnibus (GEO) to generate a unified list of differentially expressed (DE) genes. Methylome and proteomic data were integrated to our analysis to give further support to our findings. Genes that were overexpressed in TNBC were then curated to retain new potentially druggable targets based on in silico analysis. Knocking-down was used to assess gene importance for TNBC cell proliferation. Our pipeline analysis generated a list of 243 potential new targets for treating TNBC. We finally demonstrated that knock-down of Guanylate-Binding Protein 1 (GBP1 ), one of the candidate genes, selectively affected the growth of TNBC cell lines. Moreover, we showed that GBP1 expression was controlled by epidermal growth factor receptor (EGFR) in breast cancer cell lines. We propose that GBP1 is a new potential druggable therapeutic target for treating TNBC with enhanced EGFR expression.
- 11 July 2017
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 16 (9) , 3147-3157
Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation
Ki-1/57 is a nuclear and cytoplasmic regulatory protein first identified in malignant cells from Hodgkin’s lymphoma. It is involved in gene expression regulation on both transcriptional and mRNA metabolism levels. Ki-1/57 belongs to the family of intrinsically unstructured proteins and undergoes phosphorylation by PKC and methylation by PRMT1. Previous characterization of its protein interaction profile by yeast two-hybrid screening showed that Ki-1/57 interacts with proteins of the SUMOylation machinery, the SUMO E2 conjugating enzyme UBC9 and the SUMO E3 ligase PIAS3, which suggested that Ki-1/57 could be involved with this process. Here we identified seven potential SUMO target sites (lysine residues) on Ki-1/57 sequence and observed that Ki-1/57 is modified by SUMO proteins in vitro and in vivo. We showed that SUMOylation of Ki-1/57 occurred on lysines 213, 276, and 336. In transfected cells expressing FLAG-Ki-1/57 wild-type, its paralog FLAG-CGI-55 wild-type, or their non-SUMOylated triple mutants, the number of PML-nuclear bodies (PML-NBs) is reduced compared with the control cells not expressing the constructs. More interestingly, after treating cells with arsenic trioxide (As2O3), the number of PML-NBs is no longer reduced when the non-SUMOylated triple mutant Ki-1/57 is expressed, suggesting that the SUMOylation of Ki-1/57 has a role in the control of As2O3-induced PML-NB formation. A proteome-wide analysis of Ki-1/57 partners in the presence of either SUMO-1 or SUMO-2 suggests that the involvement of Ki-1/57 with the regulation of gene expression is independent of the presence of either SUMO-1 or SUMO-2; however, the presence of SUMO-1 strongly influences the interaction of Ki-1/57 with proteins associated with cellular metabolism, maintenance, and cell cycle.
- 11 July 2017
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 16 (9) , 3147-3157
Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation
Ki-1/57 is a nuclear and cytoplasmic regulatory protein first identified in malignant cells from Hodgkin’s lymphoma. It is involved in gene expression regulation on both transcriptional and mRNA metabolism levels. Ki-1/57 belongs to the family of intrinsically unstructured proteins and undergoes phosphorylation by PKC and methylation by PRMT1. Previous characterization of its protein interaction profile by yeast two-hybrid screening showed that Ki-1/57 interacts with proteins of the SUMOylation machinery, the SUMO E2 conjugating enzyme UBC9 and the SUMO E3 ligase PIAS3, which suggested that Ki-1/57 could be involved with this process. Here we identified seven potential SUMO target sites (lysine residues) on Ki-1/57 sequence and observed that Ki-1/57 is modified by SUMO proteins in vitro and in vivo. We showed that SUMOylation of Ki-1/57 occurred on lysines 213, 276, and 336. In transfected cells expressing FLAG-Ki-1/57 wild-type, its paralog FLAG-CGI-55 wild-type, or their non-SUMOylated triple mutants, the number of PML-nuclear bodies (PML-NBs) is reduced compared with the control cells not expressing the constructs. More interestingly, after treating cells with arsenic trioxide (As2O3), the number of PML-NBs is no longer reduced when the non-SUMOylated triple mutant Ki-1/57 is expressed, suggesting that the SUMOylation of Ki-1/57 has a role in the control of As2O3-induced PML-NB formation. A proteome-wide analysis of Ki-1/57 partners in the presence of either SUMO-1 or SUMO-2 suggests that the involvement of Ki-1/57 with the regulation of gene expression is independent of the presence of either SUMO-1 or SUMO-2; however, the presence of SUMO-1 strongly influences the interaction of Ki-1/57 with proteins associated with cellular metabolism, maintenance, and cell cycle.
- Open Access
- 1 January 2017
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 28 (9) , 1715-1724
Tailored Silica Nanoparticles Surface to Increase Drug Load and Enhance Bactericidal Response
- 1 January 2017
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 28 (9) , 1715-1724
Open AccessTailored Silica Nanoparticles Surface to Increase Drug Load and Enhance Bactericidal Response
- 8 March 2016
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 32 (13) , 3217-3225
Functionalized Silica Nanoparticles As an Alternative Platform for Targeted Drug-Delivery of Water Insoluble Drugs
The selective action of drugs in tumor cells is a major problem in cancer therapy. Most chemotherapy drugs act nonspecifically and damage both cancer and healthy cells causing various side effects. In this study, the preparation of a selective drug delivery system, which is able to act as a carrier for hydrophobic and anticancer drugs is reported. Amino-functionalized silica nanoparticles loaded with curcumin were successfully synthesized via sol–gel approach and duly characterized. Thereafter, the targeting ligand, folate, was covalently attached to amino groups of nanoparticle surface through amide bond formation. The cytotoxic effect of nanoparticles on prostate cancer cells line was evaluated and compared to normal cells line (prostate epithelial cell). Cytotoxicity experiments demonstrated that folate-functionalized nanoparticles were significantly cytotoxic to tumor cells, whereas normal cells were much less affected by the presence of these structures.
- 8 March 2016
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 32 (13) , 3217-3225
Functionalized Silica Nanoparticles As an Alternative Platform for Targeted Drug-Delivery of Water Insoluble Drugs
The selective action of drugs in tumor cells is a major problem in cancer therapy. Most chemotherapy drugs act nonspecifically and damage both cancer and healthy cells causing various side effects. In this study, the preparation of a selective drug delivery system, which is able to act as a carrier for hydrophobic and anticancer drugs is reported. Amino-functionalized silica nanoparticles loaded with curcumin were successfully synthesized via sol–gel approach and duly characterized. Thereafter, the targeting ligand, folate, was covalently attached to amino groups of nanoparticle surface through amide bond formation. The cytotoxic effect of nanoparticles on prostate cancer cells line was evaluated and compared to normal cells line (prostate epithelial cell). Cytotoxicity experiments demonstrated that folate-functionalized nanoparticles were significantly cytotoxic to tumor cells, whereas normal cells were much less affected by the presence of these structures.
- 1 December 2014
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1843 (12) , 2944-2956
Ki-1/57 and CGI-55 ectopic expression impact cellular pathways involved in proliferation and stress response regulation
- 1 December 2014
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1843 (12) , 2944-2956
Ki-1/57 and CGI-55 ectopic expression impact cellular pathways involved in proliferation and stress response regulation
- 18 June 2014
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 30 (25) , 7456-7464
Tailored Silica–Antibiotic Nanoparticles: Overcoming Bacterial Resistance with Low Cytotoxicity
New and more aggressive antibiotic resistant bacteria arise at an alarming rate and represent an ever-growing challenge to global health care systems. Consequently, the development of new antimicrobial agents is required to overcome the inefficiency of conventional antibiotics and bypass treatment limitations related to these pathologies. In this study, we present a synthesis protocol, which was able to entrap tetracycline antibiotic into silica nanospheres. Bactericidal efficacy of these structures was tested against bacteria that were susceptible and resistant to antibiotics. For nonresistant bacteria, our composite had bactericidal efficiency comparable to that of free-tetracycline. On the other hand, the synthesized composites were able to avoid bacterial growth of resistant bacteria while free-tetracycline has shown no significant bactericidal effect. Finally, we have investigated the cytotoxicity of these nanoparticles against mammalian cells to check any possible poisoning effect. It was found that these nanospheres are not apoptosis-inducers and only a reduction on the cell replication rate was seen when compared to the control without nanoparticles.
- 18 June 2014
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 30 (25) , 7456-7464
Tailored Silica–Antibiotic Nanoparticles: Overcoming Bacterial Resistance with Low Cytotoxicity
New and more aggressive antibiotic resistant bacteria arise at an alarming rate and represent an ever-growing challenge to global health care systems. Consequently, the development of new antimicrobial agents is required to overcome the inefficiency of conventional antibiotics and bypass treatment limitations related to these pathologies. In this study, we present a synthesis protocol, which was able to entrap tetracycline antibiotic into silica nanospheres. Bactericidal efficacy of these structures was tested against bacteria that were susceptible and resistant to antibiotics. For nonresistant bacteria, our composite had bactericidal efficiency comparable to that of free-tetracycline. On the other hand, the synthesized composites were able to avoid bacterial growth of resistant bacteria while free-tetracycline has shown no significant bactericidal effect. Finally, we have investigated the cytotoxicity of these nanoparticles against mammalian cells to check any possible poisoning effect. It was found that these nanospheres are not apoptosis-inducers and only a reduction on the cell replication rate was seen when compared to the control without nanoparticles.
- Open Access
- 1 September 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (39) , 28009-28020
Active Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor
- 1 September 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (39) , 28009-28020
Open AccessActive Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor
- 1 September 2013
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 9 (11) , 1817-1826
Sweeter But Deadlier: Decoupling Size, Charge and Capping Effects in Carbohydrate Coated Bactericidal Silver Nanoparticles
Silver nanoparticles are widely used due to their biomedical-antibacterial applications. At the same time, the stabilization of these nanoparticles is challenging and may be made using polymeric carbohydrates, based on the practice of avoiding toxic chemicals and undesirable residues. In this study, we synthesized silver nanoparticles (AgNPs) which were stabilized by carbohydrates (potato starch and chitosan) and characterized by UV-Vis spectroscopy, zeta potential and transmission electron microscopy techniques. Bactericidal efficiency of AgNPs capped with different carbohydrates was tested demonstrating that the synthesized materials were able to inhibit the growth of two clinical/medical relevant bacteria strains (Escherichia coli and Staphylococcus aureus). AgNPs stabilized by chitosan presented enhanced bactericidal activity if compared to the ones synthesized in presence of potato starch. This difference is mainly attributed to the known antibacterial properties of chitosan associated to overall positive charge of the nanoparticles capped by this polymer. Those nanoparticles obtained in presence of starch presented minor bactericidal effects since the starch-capping agent is not able to contribute to the avoidance of bacteria growth and confers a quasi-neutral charge to the nanoparticle.
- 1 September 2013
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 9 (11) , 1817-1826
Sweeter But Deadlier: Decoupling Size, Charge and Capping Effects in Carbohydrate Coated Bactericidal Silver Nanoparticles
Silver nanoparticles are widely used due to their biomedical-antibacterial applications. At the same time, the stabilization of these nanoparticles is challenging and may be made using polymeric carbohydrates, based on the practice of avoiding toxic chemicals and undesirable residues. In this study, we synthesized silver nanoparticles (AgNPs) which were stabilized by carbohydrates (potato starch and chitosan) and characterized by UV-Vis spectroscopy, zeta potential and transmission electron microscopy techniques. Bactericidal efficiency of AgNPs capped with different carbohydrates was tested demonstrating that the synthesized materials were able to inhibit the growth of two clinical/medical relevant bacteria strains (Escherichia coli and Staphylococcus aureus). AgNPs stabilized by chitosan presented enhanced bactericidal activity if compared to the ones synthesized in presence of potato starch. This difference is mainly attributed to the known antibacterial properties of chitosan associated to overall positive charge of the nanoparticles capped by this polymer. Those nanoparticles obtained in presence of starch presented minor bactericidal effects since the starch-capping agent is not able to contribute to the avoidance of bacteria growth and confers a quasi-neutral charge to the nanoparticle.
- 30 July 2012
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry
- Vol. 22 (43) , 22851-22858
Mechanism of interaction between colloids and bacteria as evidenced by tailored silica–lysozyme composites
The ever increasing antibiotic resistance levels in pathogenic and non-pathogenic bacteria have boosted the search for effective controlling methods of bacterial infections. In this context, we prepared colloidal silica–lysozyme composites to evaluate the interaction between these structures and bacteria. Lysozyme was chosen since it is a protein that holds bactericidal properties and that, in the reaction process, acts as a catalyst which favors silica hydrolysis and condensation. The high entrapment yield of lysozyme in the silica cage (approximately 95%) does not change the secondary structure of the protein resulting in a material with superior bactericidal properties. The antimicrobial differences when silica–lysozyme composites are tested against Escherichia coli and Staphylococcus aureus are used to propose an interaction mechanism between colloids and bacteria. Bactericidal properties of the composites are attributed to the ultra-structural organization of the composite which, due to the positive surface charge, is attracted by the negative bacterial cell wall while lysozyme is delivered.
- 30 July 2012
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry
- Vol. 22 (43) , 22851-22858
Mechanism of interaction between colloids and bacteria as evidenced by tailored silica–lysozyme composites
The ever increasing antibiotic resistance levels in pathogenic and non-pathogenic bacteria have boosted the search for effective controlling methods of bacterial infections. In this context, we prepared colloidal silica–lysozyme composites to evaluate the interaction between these structures and bacteria. Lysozyme was chosen since it is a protein that holds bactericidal properties and that, in the reaction process, acts as a catalyst which favors silica hydrolysis and condensation. The high entrapment yield of lysozyme in the silica cage (approximately 95%) does not change the secondary structure of the protein resulting in a material with superior bactericidal properties. The antimicrobial differences when silica–lysozyme composites are tested against Escherichia coli and Staphylococcus aureus are used to propose an interaction mechanism between colloids and bacteria. Bactericidal properties of the composites are attributed to the ultra-structural organization of the composite which, due to the positive surface charge, is attracted by the negative bacterial cell wall while lysozyme is delivered.
- 19 July 2011
- Published by Wiley in FEBS Letters
- Vol. 585 (16) , 2556-2560
Evidence for the association of the human regulatory protein Ki-1/57 with the translational machinery
Ki-1/57 is a cytoplasmic and nuclear protein of 57 kDa first identified in malignant cells from Hodgkin's lymphoma. Based on yeast-two hybrid protein interaction we found out that Ki-1/57 interacts with adaptor protein RACK1 (receptor of activated kinase 1), CIRP (cold-inducible RNA-binding protein), RPL38 (ribosomal protein L38) and FXR1 (fragile X mental retardation-related protein 1). Since these proteins are involved in the regulation of translation we suspected that Ki-1/57 may have a role in it. We show by immunoprecipitation the association of Ki-1/57 with FMRP. Confocal microscopy revealed that Ki-1/57 colocalizes with FMRP/FXR1/2 to stress granules. Furthermore Ki-1/57 cosediments with free ribosomal particles and enhances translation, when tethered to a reporter mRNA, suggesting that Ki-1/57 may be involved in translational regulation.
- 19 July 2011
- Published by Wiley in FEBS Letters
- Vol. 585 (16) , 2556-2560
Evidence for the association of the human regulatory protein Ki-1/57 with the translational machinery
Ki-1/57 is a cytoplasmic and nuclear protein of 57 kDa first identified in malignant cells from Hodgkin's lymphoma. Based on yeast-two hybrid protein interaction we found out that Ki-1/57 interacts with adaptor protein RACK1 (receptor of activated kinase 1), CIRP (cold-inducible RNA-binding protein), RPL38 (ribosomal protein L38) and FXR1 (fragile X mental retardation-related protein 1). Since these proteins are involved in the regulation of translation we suspected that Ki-1/57 may have a role in it. We show by immunoprecipitation the association of Ki-1/57 with FMRP. Confocal microscopy revealed that Ki-1/57 colocalizes with FMRP/FXR1/2 to stress granules. Furthermore Ki-1/57 cosediments with free ribosomal particles and enhances translation, when tethered to a reporter mRNA, suggesting that Ki-1/57 may be involved in translational regulation.